Xi Tang
- Molecular Biology
- Oncology top 5%
- Cancer Research top 5%
- Pharmacology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Frank A. SinicropeElizabeth HalfKarin GwynAyşegül A. ŞahinYunjie SunM. Tien KuoIgnacio I. WistubaAnne S. Tsao
- Topics
- Lung Cancer Treatments and Mutations (10 papers)Colorectal Cancer Treatments and Studies (5 papers)HER2/EGFR in Cancer Research (4 papers)
- Cited by
- Cancer ResearchOncologyPharmacology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xi Tang
34 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 623
- Oncology 553
- Cancer Research 365
- Pharmacology 338
- Pulmonary and Respiratory Medicine 330
Countries citing papers authored by Xi Tang
This map shows the geographic impact of Xi Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Tang more than expected).
Fields of papers citing papers by Xi Tang
This network shows the impact of papers produced by Xi Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Tang. The network helps show where Xi Tang may publish in the future.
Co-authorship network of co-authors of Xi Tang
This figure shows the co-authorship network connecting the top 25 collaborators of Xi Tang. A scholar is included among the top collaborators of Xi Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Tang. Xi Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 29 | |
| 6 | 6 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 8 | |
| 10 | 8 | |
| 11 | 29 | |
| 12 | 4 | |
| 13 | 39 | |
| 14 | 20 | |
| 15 | 41 | |
| 16 | 235 | |
| 17 | 15 | |
| 18 | 97 | |
| 19 | [HER2 expression and its prognostic implication in lymph node negative breast carcinoma: a Meta-analysis]. | 5 |
| 20 | Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. | 288 |
About Xi Tang
Xi Tang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Cancer Research (365 citations), Oncology (553 citations) and Pharmacology (338 citations). Xi Tang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Frank A. Sinicrope, Elizabeth Half, Karin Gwyn, Ayşegül A. Şahin, Yunjie Sun, M. Tien Kuo, Ignacio I. Wistuba, Anne S. Tsao, Hai T. Tran and Robert Lemos. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.